CME Group, Inc.

CME Group, Inc. has shown a significant rebound today, contrasting with a slight decline in the S&P 500. Despite recent challenges, the company reported a 22.96% net profit growth and record operating cash flow. It maintains a strong dividend yield and high institutional ownership, reflecting investor confidence.

CME Group, Inc. recently hit a 52-week low, reflecting a shift in its stock performance despite a 1-year return that lags behind the S&P 500. With a market cap of USD 105,357 million, the company maintains a P/E ratio of 26.00 and a dividend yield of 3.83%.

CME Group, Inc. has reached a new 52-week low, contrasting with its 1-year performance of 13.35%, which is below the S&P 500's return. With a market cap of USD 105,357 million, the company maintains a P/E ratio of 26.00 and a dividend yield of 3.83%.

CME Group, Inc. recently hit a 52-week low, reflecting its stock's performance fluctuations over the past year. Despite this, the company has achieved a 1-year performance of 22.05%. With a market capitalization of USD 105,357 million, it features a P/E ratio of 26.00 and a dividend yield of 3.83%.

CME Group, Inc. faced a decline in its stock price, reaching an intraday low during a challenging trading session. Despite recent decreases, the company reported strong fundamentals, including significant net profit growth and robust operating cash flow, while maintaining high institutional ownership and a substantial market capitalization.

CME Group, Inc. opened with a notable loss, continuing a trend of decline over the past month. The company, with a market capitalization of approximately USD 105.36 billion, has a P/E ratio of 26.00 and a dividend yield of 3.83%. Recent performance indicates significant volatility in its market dynamics.

CME Group, Inc. has shown strong performance today, contrasting with a decline in the S&P 500. The company reported significant net profit growth and record operating cash flow, maintaining positive results for 14 consecutive quarters. High institutional holdings reflect investor confidence, reinforcing its position in the capital markets industry.

CME Group, Inc. recently hit a 52-week low, contrasting with its previous high. Despite this, the company has seen a year-over-year performance increase, though slightly below the S&P 500. Key financial metrics include a P/E ratio of 28.00, a dividend yield of 3.59%, and a return on equity of 14.06%.

CME Group, Inc. faced a significant decline on June 1, 2026, contrasting with the S&P 500's slight gain. Despite recent drops, the company reported strong net profit growth and robust operating cash flow. With a solid market capitalization and high institutional holdings, CME Group continues to demonstrate financial strength.

CME Group, Inc. has recently revised its evaluation amid changing market conditions. The stock is priced at $296.22, reflecting a year-long performance range between $251.90 and $329.16. Technical indicators present a mixed outlook, while CME Group has outperformed the S&P 500 year-to-date.

CME Group, Inc. has recently revised its evaluation amid changing market conditions. The stock has experienced notable fluctuations over the past year, with a significant performance range. Technical indicators present mixed signals, while CME Group has outperformed the S&P 500 year-to-date, showcasing its resilience in the market.

CME Group, Inc. faced a decline on March 10, 2026, contrasting with the S&P 500's performance. Despite recent setbacks, the company has shown resilience with a year-to-date gain and strong financial metrics, including a return on equity of 14.06% and significant institutional interest.

CME Group, Inc. has recently adjusted its valuation, with its current price reflecting a slight increase. The company has shown strong performance over the past year, significantly outperforming the S&P 500. Key metrics include a P/E ratio of 26, a price-to-book value of 3.48, and a notable dividend yield.

CME Group, Inc. has achieved a new 52-week high, reflecting its strong performance in the capital markets industry with a notable one-year growth. The company, classified as large-cap, has a market capitalization of over USD 111 billion, a P/E ratio of 26.00, and a dividend yield of 1.62%.

CME Group, Inc. achieved a new 52-week high of USD 327.79, showcasing a strong one-year performance of 64.46%. With a market capitalization of USD 111,097 million, the company has a P/E ratio of 26.00 and a dividend yield of 1.62%, indicating solid financial health in the capital markets industry.

CME Group, Inc. saw a decline in stock price today, contrasting with a gain in the S&P 500. Despite this, the company has shown resilience over the past month and year, outperforming the index. With strong financial metrics and high institutional holdings, CME Group remains a significant player in the capital markets industry.

CME Group, Inc. has achieved a new 52-week high, reflecting its strong performance in the capital markets industry with a notable one-year gain. The company, with a market capitalization of USD 111,097 million, showcases solid financial metrics, including a P/E ratio of 26.00 and a return on equity of 14.06%.

CME Group, Inc. has shown strong performance in the capital markets, with significant increases over various time frames. The company maintains solid financial metrics, including a return on equity of 14.06% and a robust cash position of over USD 7 billion, reflecting investor confidence.

CME Group, Inc. has demonstrated strong performance, achieving an intraday high and a notable annual return. The company reported impressive operating cash flow and a solid return on capital employed, alongside a substantial dividend per share. High institutional holdings further enhance its market position in the capital markets industry.